Literature DB >> 10375267

Predictors of self-reported adherence in persons living with HIV disease.

W L Holzemer1, I B Corless, K M Nokes, J G Turner, M A Brown, G M Powell-Cope, J Inouye, S B Henry, P K Nicholas, C J Portillo.   

Abstract

This study examined the relationships between the five dimensions of the Wilson and Cleary model of health-related quality of life and three self-reported adherence measures in persons living with HIV using a descriptive survey design. Data collection occurred in seven cities across the United States, including university-based AIDS clinics, private practices, public and for-profit hospitals, residential and day-care facilities, community-based organizations, and home care. The three dependent adherence measures studied were "medication nonadherence," "follows provider advice," and "missed appointments." The sample included 420 persons living with HIV disease with a mean age of 39 years of which 20% were women and 51% were white; subjects had a mean CD4 count of 321 mm3. HIV-positive clients with higher symptom scores, particularly depression, were more likely to be nonadherent to medication, not to follow provider advice, and to miss appointments. Participants who reported having a meaningful life, feeling comfortable and well cared for, using their time wisely, and taking time for important things were both more adherent to their medications and more likely to follow provider's advice. No evidence was found demonstrating any relationship between adherence and age, gender, ethnicity, or history of injection drug use. These findings support the need to treat symptoms, particularly depression, and to understand clients' perceptions of their environment as strategies to enhance adherence. A limitation of this study was that adherence was measured only by self-report; however, the study did expand the concept of adherence in HIV care beyond medication adherence to include following instructions and keeping appointments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375267     DOI: 10.1089/apc.1999.13.185

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  76 in total

1.  Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.

Authors:  J H Arnsten; P A Demas; H Farzadegan; R W Grant; M N Gourevitch; C J Chang; D Buono; H Eckholdt; A A Howard; E E Schoenbaum
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

3.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

Review 4.  Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.

Authors:  Lizheng Shi; Jinan Liu; Yordanka Koleva; Vivian Fonseca; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART.

Authors:  Carol E Golin; Joanne Earp; Hsiao-Chuan Tien; Paul Stewart; Carol Porter; Lynn Howie
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

6.  A Social Problem-Solving Model of Adherence to HIV Medications.

Authors:  Mallory O Johnson; Timothy R Elliott; Torsten B Neilands; Stephen F Morin; Margaret A Chesney
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

Review 7.  The HIV epidemic among individuals with mental illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

8.  Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study.

Authors:  M Guilera; M Fuentes; M Grifols; J Ferrer; X Badia
Journal:  Osteoporos Int       Date:  2005-12-31       Impact factor: 4.507

9.  Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.

Authors:  Heather J Ribaudo; Kimberly Y Smith; Gregory K Robbins; Charles Flexner; Richard Haubrich; Yun Chen; Margaret A Fischl; Bruce R Schackman; Sharon A Riddler; Roy M Gulick
Journal:  Clin Infect Dis       Date:  2013-09-17       Impact factor: 9.079

10.  Participants' perspectives on cognitive-behavioral therapy for adherence and depression in HIV.

Authors:  Carla Berg; Sudha Raminani; Joseph Greer; Meaghan Harwood; Steven Safren
Journal:  Psychother Res       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.